Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tuksin Jearanaiwitayakul, Panya Sunintaboon, Runglawan Chawengkittikul, Jitra Limthongkul, Panuwat Midoeng, Preamrudee Chaisuwirat, Saradee warit & Sukathida Ubol. (2021) Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models. Human Vaccines & Immunotherapeutics 17:8, pages 2793-2807.
Read now
Read now
Yan Shi, Minna Guo, Wenjing Yang, Shijiang Liu, Bin Zhu, Ling Yang, Chun Yang & Cunming Liu. (2021) Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases?. Expert Review of Vaccines 20:4, pages 375-383.
Read now
Read now
Qiuhui Li, Huiya Ma, Yuanyuan Zhang, Kun Feng, Pengfei Yang, Jianjun Li, Hongli Zhu, Chao Chen & Kunping Yan. (2018) HPLC method for Residual 2-Bromoethylamine Hydrobromide in Hemoglobin-based Oxygen Carriers Derived with 4-Methoxybenzenesulfonyl Chloride. Journal of Liquid Chromatography & Related Technologies 41:13-14, pages 819-824.
Read now
Read now
Articles from other publishers (116)
Gwen DuytschaeverPatrícia R. Ströher, Kevin FonsecaFrank van der MeerAmanda D. Melin. (2023) Effectiveness of TRIzol in Inactivating Animal Pathogens. Applied Biosafety 28:4, pages 230-241.
Crossref
Crossref
Erika Yan Wang, Morteza Sarmadi, Binbin Ying, Ana Jaklenec & Robert Langer. (2023) Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines. Biomaterials 303, pages 122345.
Crossref
Crossref
D.D. Zhdanov, Yu.Yu. Ivin, A.N. Shishparenok, S.V. Kraevskiy, S.L. Kanashenko, L.E. Agafonova, V.V. Shumyantseva, O.V. Gnedenko, A.N. Pinyaeva, A.A. Kovpak, A.A. Ishmukhametov & A.I. Archakov. (2023) Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example. Biomeditsinskaya Khimiya 69:5, pages 253-280.
Crossref
Crossref
Eun-Ha Kim & Su-Jin Park. (2023) Emerging Tick-Borne Dabie bandavirus: Virology, Epidemiology, and Prevention. Microorganisms 11:9, pages 2309.
Crossref
Crossref
Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, Anh Tran, John Kelly, Sabahudin Hrapovic, Anna Robotham, Arsalan Haqqani, Alexandra Star, Tyler M. Renner, Julie Blouin, Jean-Sébastien Maltais, Brian Cass, Kai Cui, Jae-Young Cho, Xinyu Wang, Daria Zoubchenok, Renu Dudani, Diana Duque, Michael J. McCluskie & Yves Durocher. (2023) Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells. Communications Medicine 3:1.
Crossref
Crossref
Sumin Han, Panjae Lee & Hyo-Jick Choi. (2023) Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants. Pharmaceutics 15:8, pages 2114.
Crossref
Crossref
Marlena M. Westcott, Maria Blevins, Thomas F. Wierzba, Alexis E. Morse, Kinnede R. White, Leigh Ann Sanders & John W. Sanders. (2023) The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin. Microorganisms 11:8, pages 2040.
Crossref
Crossref
Hai Xu, Shanyuan Zhu, Roshini Govinden & Hafizah Y. Chenia. (2023) Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus. Viruses 15:8, pages 1694.
Crossref
Crossref
Lulu Han, Shuai Song, Huilin Feng, Jing Ma, Wenqiang Wei & Fusheng Si. (2023) A roadmap for developing Venezuelan equine encephalitis virus (VEEV) vaccines: Lessons from the past, strategies for the future. International Journal of Biological Macromolecules 245, pages 125514.
Crossref
Crossref
Andy Ka Chun Kan & Philip Hei Li. (2023) Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin. Immunology Letters 259, pages 21-23.
Crossref
Crossref
Mariana Pierre de Barros Gomes, José Henrique Rezende Linhares, Tiago Pereira dos Santos, Renata Carvalho Pereira, Renata Tourinho Santos, Stephanie Almeida da Silva, Marta Cristina de Oliveira Souza, Juliana Fernandes Amorim da Silva, Gisela Freitas Trindade, Viviane Silva Gomes, Débora Ferreira Barreto-Vieira, Milena Mouta Verdan França Carvalho, Ana Paula Dinis Ano Bom, Noemi Rovaris Gardinali, Rodrigo Müller, Nathalia dos Santos Alves, Luma da Cruz Moura, Patrícia Cristina da Costa Neves, Gabriela Santos Esteves, Waleska Dias Schwarcz, Sotiris Missailidis, Ygara da Silva Mendes & Sheila Maria Barbosa de Lima. (2023) Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials. Viruses 15:7, pages 1486.
Crossref
Crossref
Kuanish K. Jekebekov, Nurika N. Assanzhanova, Ainur S. Nurpeisova, Sholpan Zh. Ryskeldinova, Zharkinay S. Absatova, Zhandos S. Abay, Yeraly A. Shayakhmetov, Alisher D. Omurtay, Sabina U. Moldagulova, Elina Zh. Kalimolda, Sandugash O. Sadikalieva, Kamshat A. Shorayeva & Kunsulu D. Zakarya. (2023) Selection of conditions for effective inactivation of <i>Pseudopestis avium</i> virus (Paramyxoviridae: <i>Orthoavulovirus: Avian orthoavulovirus</i> 1) for the production of a Newcastle disease vaccine. Problems of Virology 68:2, pages 124-131.
Crossref
Crossref
Kuandyk Zhugunissov, Muratbay Mambetaliyev, Nuraiym Sarsenkulova, Shalkar Tabys, Marzhan Kenzhebaeva, Arman Issimov & Yergali Abduraimov. (2023) Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels. Animals 13:9, pages 1513.
Crossref
Crossref
Yukyu Chan & Yihan Hua. (2023) Immune System Mechanism and Vaccination of SARS-Cov-2. Highlights in Science, Engineering and Technology 45, pages 280-285.
Crossref
Crossref
Sudip Kumar Dutta & Thomas Langenburg. (2023) A Perspective on Current Flavivirus Vaccine Development: A Brief Review. Viruses 15:4, pages 860.
Crossref
Crossref
Soohyun Park & Nam-Joon Cho. (2022) Lipid Membrane Interface Viewpoint: From Viral Entry to Antiviral and Vaccine Development. Langmuir 39:1, pages 1-11.
Crossref
Crossref
Hyeran Won, Ah-Ra Kim, Gyung Tae Chung, Su Hwan Kim, Jung-Sik Yoo & June-Woo Lee. (2023) Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice. Vaccines 11:1, pages 106.
Crossref
Crossref
Gourab Das, Suman Nayak, Dinesh Kumar Kotness & Prolay Das. (2023) A biomass-derived dual crosslinked DNA-nanoparticle hydrogel for visible light-induced photodynamic bacterial inactivation. Soft Matter.
Crossref
Crossref
Priya Shrivastava & Suresh P. Vyas. 2023. Viral Drug Delivery Systems. Viral Drug Delivery Systems
269
294
.
Supasek Kongsomros, Nutkridta Pongsakul, Jirawan Panachan, Ladawan Khowawisetsut, Jinjuta Somkird, Chak Sangma, Tapanee Kanjanapruthipong, Patompon Wongtrakoongate, Arthit Chairoungdua, Kovit Pattanapanyasat, David S. Newburg, Ardythe L. Morrow, Suradej Hongeng, Arunee Thitithanyanont & Somchai Chutipongtanate. (2022) Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS‐CoV‐2 infected human lung epithelial cells. Journal of Extracellular Vesicles 11:12.
Crossref
Crossref
Chidozie Clifford Ugwu, Mohd Hair-Bejo, Mat Isa Nurulfiza, Abdul Rahman Omar & Aini Ideris. (2022) Efficacy, humoral, and cell-mediated immune response of inactivated fowl adenovirus 8b propagated in chicken embryo liver cells using bioreactor in broiler chickens. Veterinary World, pages 2681-2692.
Crossref
Crossref
Nayoung Kim, Tae-Young Lee, Hansaem Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee & Hyun-Joo Kim. (2022) Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice. Vaccines 10:11, pages 1843.
Crossref
Crossref
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, Eloi Parladé, Esther Vázquez, José Luis Corchero, Neus Ferrer-Miralles & Antonio Villaverde. (2022) Recombinant vaccines in 2022: a perspective from the cell factory. Microbial Cell Factories 21:1.
Crossref
Crossref
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag A. Patel, Rajashri Bezbaruah, Aayushi B. Patel & Zhe-Sheng Chen. (2022) Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world. Frontiers in Immunology 13.
Crossref
Crossref
Libia Milena Hernandez, K. Sumathy, Sushant Sahastrabuddhe, Jean-Louis Excler, Sonali Kochhar, Emily R. Smith, Marc Gurwith & Robert T. Chen. (2022) A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus. Vaccine 40:35, pages 5263-5274.
Crossref
Crossref
Pitakthai Chamtim, Eukote Suwan, Ha Thanh Dong, Soranuth Sirisuay, Nontawith Areechon, Eakapol Wangkahart, Ikuo Hirono, Rapeepat Mavichak & Sasimanas Unajak. (2022) Combining segments 9 and 10 in DNA and recombinant protein vaccines conferred superior protection against tilapia lake virus in hybrid red tilapia (oreochromis sp.) compared to single segment vaccines. Frontiers in Immunology 13.
Crossref
Crossref
Siew Suan Ng, Hooi Ling Lee, Pandian Bothi Raja & Ruey‐an Doong. (2022) Recent Advances in Nanomaterial‐based Optical Biosensors as Potential Point‐of‐Care Testing (PoCT) Probes in Carcinoembryonic Antigen Detection. Chemistry – An Asian Journal 17:14.
Crossref
Crossref
Alessio Bortolami, Eva Mazzetto, Richard Thiga Kangethe, Viskam Wijewardana, Mario Barbato, Luca Porfiri, Silvia Maniero, Elisa Mazzacan, Jane Budai, Sabrina Marciano, Valentina Panzarin, Calogero Terregino, Francesco Bonfante & Giovanni Cattoli. (2022) Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes. Frontiers in Veterinary Science 9.
Crossref
Crossref
Emerson de Castro Barbosa, Adriana de Souza Andrade, Myrian Morato Duarte, Gilson Faria, Felipe Campos de Melo Iani, Ana Caroline Zampiroli Ataide, Lucas Maciel Cunha, Clara Guerra Duarte, Sílvia Ligorio Fialho & Sérgio Caldas. (2022) Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model. Molecular Immunology 147, pages 199-208.
Crossref
Crossref
Fatima Naz Naeem, Syeda Fatima Saba Hasan, Muskaan Doulat Ram, Summaiyya Waseem, Syed Hassan Ahmed & Taha Gul Shaikh. (2022) The association between SARS-CoV-2 vaccines and transverse myelitis: A review. Annals of Medicine and Surgery 79, pages 103870.
Crossref
Crossref
Karolina Kulig, Magdalena Ziąbka, Kacper Pilarczyk, Aleksandra Owczarzy, Wojciech Rogóż & Małgorzata Maciążek-Jurczyk. (2022) Physicochemical Study of Albumin Nanoparticles with Chlorambucil. Processes 10:6, pages 1170.
Crossref
Crossref
Nishta Krishnan, Luke J. Kubiatowicz, Maya Holay, Jiarong Zhou, Ronnie H. Fang & Liangfang Zhang. (2022) Bacterial membrane vesicles for vaccine applications. Advanced Drug Delivery Reviews 185, pages 114294.
Crossref
Crossref
Saeed Khoshnood, Maniya Arshadi, Sousan Akrami, Maryam Koupaei, Hossein Ghahramanpour, Aref Shariati, Nourkhoda Sadeghifard & Mohsen Heidary. (2022) An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines. Journal of Clinical Laboratory Analysis 36:5.
Crossref
Crossref
Syed Hassan Ahmed, Summaiyya Waseem, Taha Gul Shaikh, Nashwa Abdul Qadir, Sarush Ahmed Siddiqui, Irfan Ullah, Abdul Waris & Zohaib Yousaf. (2022) SARS-CoV-2 vaccine-associated-tinnitus: A review. Annals of Medicine and Surgery 75, pages 103293.
Crossref
Crossref
Angus Nnamdi Oli & Adekunle Babajide Rowaiye. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research
31
55
.
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics
163
200
.
Jasmin Fertey, Bastian Standfest, Jana Beckmann, Martin Thoma, Thomas Grunwald & Sebastian Ulbert. 2022. Bacterial Vaccines. Bacterial Vaccines
97
113
.
Alberto Falco, Melissa Bello-Perez, Rocío Díaz-Puertas, Matthew Mold & Mikolaj Adamek. (2021) Update on the Inactivation Procedures for the Vaccine Development Prospects of a New Highly Virulent RGNNV Isolate. Vaccines 9:12, pages 1441.
Crossref
Crossref
Thao Thu Mai, Pattanapon Kayansamruaj, Suwimon Taengphu, Saengchan Senapin, Janina Z. Costa, Jorge del‐Pozo, Kim D. Thompson, Channarong Rodkhum & Ha Thanh Dong. (2021)
Efficacy of heat‐killed and formalin‐killed vaccines against
Tilapia tilapinevirus
in juvenile Nile tilapia (
Oreochromis niloticus
)
. Journal of Fish Diseases 44:12, pages 2097-2109.
Crossref
Crossref
Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, Negin Noorbakhsh, Negin Borzooee Moghadam & Matin Mamoudifard. (2021) A comprehensive review on efficient approaches for combating coronaviruses. Biomedicine & Pharmacotherapy 144, pages 112353.
Crossref
Crossref
G. M. Ignatyev, K. V. Kaa, L. P. Antonova, A. V. Atrasheuskaya & A. A. Ishmukhametov. (2021) Immunogenic properties of the preparation containing the Chikungunya virus antigen inactivated by β-propiolactone. Journal of microbiology, epidemiology and immunobiology 98:5, pages 519-527.
Crossref
Crossref
Divya Gupta, Haripriya Parthasarathy, Vishal Sah, Dixit Tandel, Dhiviya Vedagiri, Shashikala Reddy & Krishnan H Harshan. (2021) Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential. Virus Research 305, pages 198555.
Crossref
Crossref
Essa M. Saied, Yousra A. El-Maradny, Alaa A. Osman, Amira M. G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, Magdalena Piekutowska, Mohamed A. Abdel-Rahman, Bassem A. Balbool & Ahmed M. Abdel-Azeem. (2021) A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Pharmaceutics 13:11, pages 1759.
Crossref
Crossref
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi & Hossein Samadi Kafil. (2021) SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. International Journal of Biological Macromolecules 188, pages 740-750.
Crossref
Crossref
Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris & Mohamed M. Abdel-Daim. (2021) Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19. Inflammopharmacology 29:5, pages 1331-1346.
Crossref
Crossref
Kuandyk Zhugunissov, Kunsulu Zakarya, Berik Khairullin, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Kulyaisan Sultankulova, Aslan Kerimbayev, Sergazy Nurabayev, Balzhan Myrzakhmetova, Aziz Nakhanov, Ainur Nurpeisova, Olga Chervyakova, Nurika Assanzhanova, Yerbol Burashev, Muratbay Mambetaliyev, Moldir Azanbekova, Syrym Kopeyev, Nurlan Kozhabergenov, Aisha Issabek, Moldir Tuyskanova & Lespek Kutumbetov. (2021) Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters. Frontiers in Microbiology 12.
Crossref
Crossref
Kevin R. Bewley, Karen GoochKelly M. Thomas, Stephanie LongetNathan WiblinLaura HunterKin ChanPhillip Brown, Rebecca A. Russell, Catherine HoGillian SlackHolly E. Humphries, Leonie AldenLauren Allen, Marilyn Aram, Natalie BakerEmily BruntRebecca CobbSusan FotheringhamDebbie HarrisChelsea KennardStephanie Leung, Kathryn Ryan, Howard TolleyNadina WandAndrew White, Laura Sibley, Charlotte Sarfas, Geoff PearsonEmma RaynerXiaochao XueTeresa Lambe, Sue CharltonSarah Gilbert, Quentin J. Sattentau, Fergus GleesonYper Hall, Simon FunnellSally SharpeFrancisco J. SalgueroAndrew Gorringe & Miles Carroll. (2021) Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques. Science Advances 7:37.
Crossref
Crossref
Pin-Yu Perera & Liyanage P. Perera. (2021) Development of leading first-generation vaccines against SARS-CoV-2. Microbes and Infection 23:8, pages 104841.
Crossref
Crossref
Cristina A. Nadalutti, Rajendra Prasad & Samuel H. Wilson. (2021) Perspectives on formaldehyde dysregulation: Mitochondrial DNA damage and repair in mammalian cells. DNA Repair 105, pages 103134.
Crossref
Crossref
Franz X. Heinz & Karin Stiasny. (2021) Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. npj Vaccines 6:1.
Crossref
Crossref
Zhenzhen Zhang, Haiyan Wang, Xing Xie, Rong Chen, Jun Li, Bo Ni, Pei Yu, Zunfeng Liu, Guoqing Shao, Qiyan Xiong, Yanna Wei, Beibei Liu, Zhixin Feng, Xiang Zhou & Chao Zhang. (2021) Long‐Residence Pneumonia Vaccine Developed Using PEG‐Grafted Hybrid Nanovesicles from Cell Membrane Fusion of Mycoplasma and IFN‐γ‐Primed Macrophages. Small 17:34.
Crossref
Crossref
Fatma F. Warda, Hala El Sawy Ahmed, Nermeen G. Shafik, Christine A. Mikhael, Heba M. G. Abd-ElAziz, Walaa A. Mohammed & Eman A. Shosha. (2021) Application of equine herpesvirus-1 vaccine inactivated by both formaldehyde and binary ethylenimine in equine. Veterinary World, pages 1815-1821.
Crossref
Crossref
Bhavnita SoniRitika KabraShailza Singh. (2021) Quantitative Insight into Immunopathology of SARS-CoV-2 Infection. Journal of Interferon & Cytokine Research 41:7, pages 244-257.
Crossref
Crossref
Fouad A. Abolaban & Fathi M. Djouider. (2021) Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development. Open Life Sciences 16:1, pages 558-570.
Crossref
Crossref
Weiwei Zeng, Yingying Wang, Xiaoyu Chen, Qing Wang, Sven M. Bergmann, Ying Yang, Yahui Wang, Bo Li, Yuefeng Lv, Hua Li & Wensheng Lan. (2021) Potency and efficacy of VP20-based vaccine against tilapia lake virus using different prime-boost vaccination regimens in tilapia. Aquaculture 539, pages 736654.
Crossref
Crossref
Yulema Valero, José G. Olveira, Carmen López-Vázquez, Carlos P. Dopazo & Isabel Bandín. (2021) BEI Inactivated Vaccine Induces Innate and Adaptive Responses and Elicits Partial Protection upon Reassortant Betanodavirus Infection in Senegalese Sole. Vaccines 9:5, pages 458.
Crossref
Crossref
Cielo García-Montero, Oscar Fraile-Martínez, Coral Bravo, Diego Torres-Carranza, Lara Sanchez-Trujillo, Ana M. Gómez-Lahoz, Luis G. Guijarro, Natalio García-Honduvilla, Angel Asúnsolo, Julia Bujan, Jorge Monserrat, Encarnación Serrano, Melchor Álvarez-Mon, Juan A De León-Luis, Miguel A. Álvarez-Mon & Miguel A. Ortega. (2021) An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines 9:5, pages 433.
Crossref
Crossref
Izabela K Ragan, Lindsay M Hartson, Taru S Dutt, Andres Obregon-Henao, Rachel M Maison, Paul Gordy, Amy Fox, Burton R Karger, Shaun T Cross, Marylee L Kapuscinski, Sarah K Cooper, Brendan K Podell, Mark D Stenglein, Richard A Bowen, Marcela Henao-Tamayo & Raymond P Goodrich. (2021) A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model. Vaccines 9:4, pages 340.
Crossref
Crossref
Hu-Dachuan Jiang, Jing-Xin Li, Peng Zhang, Xiang Huo & Feng-Cai Zhu. (2021) The COVID-19 Vaccine in Clinical Trials: Where Are We Now?. Infectious Diseases & Immunity 1:1, pages 43-51.
Crossref
Crossref
Peiyang Li, Jacek Koziel, Jeffrey Zimmerman, Jianqiang Zhang, Ting-Yu Cheng, Wannarat Yim-Im, William Jenks, Myeongseong Lee, Baitong Chen & Steven Hoff. (2021) Mitigation of Airborne PRRSV Transmission with UV Light Treatment: Proof-of-Concept. Agriculture 11:3, pages 259.
Crossref
Crossref
Raquel L. RussellPeter PelkaBrian L. Mark. (2021) Frontrunners in the race to develop a SARS-CoV-2 vaccine. Canadian Journal of Microbiology 67:3, pages 189-212.
Crossref
Crossref
Ecem Saygili, Ece Yildiz-Ozturk, Macauley J. Green, Amir M. Ghaemmaghami & Ozlem Yesil-Celiktas. (2021) Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response. Biomicrofluidics 15:2.
Crossref
Crossref
Nicolas Malausse, Sylvie van der Werf, Nadia Naffakh & Sandie Munier. (2021) Influenza B Virus Infection Is Enhanced Upon Heterotypic Co-infection With Influenza A Virus. Frontiers in Microbiology 12.
Crossref
Crossref
Naor Bar-Zeev & Sonali Kochhar. (2021) Expecting the unexpected with COVID-19 vaccines. The Lancet Infectious Diseases 21:2, pages 150-151.
Crossref
Crossref
Weiwei Zeng, Yingying Wang, Huzi Hu, Qing Wang, Sven M. Bergmann, Yahui Wang, Bo Li, Yuefeng Lv, Hua Li, Jiyuan Yin & Yingying Li. (2021) Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia. Vaccines 9:2, pages 86.
Crossref
Crossref
Rania Ibrahim Shebl, Mohamed E. Amer, Tamer M. M. Abuamara, Emadeldin R. Matar, Hassan Fathy Ahmed, Tamer Albasyoni Gomah, Laila E. El Moselhy, Mohammed Abu-Elghait & Aly Fahmy Mohamed. (2021)
Staphylococcus aureus
derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations
. Clinical and Experimental Vaccine Research 10:3, pages 229.
Crossref
Crossref
Zuzana Strizova, Jitka Smetanova, Jirina Bartunkova & Tomas Milota. (2021) Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology 182:4, pages 339-349.
Crossref
Crossref
Ping Wu, Yelitza Y. Rodríguez, Benjamin J. Hershey, Yadata Tadassa, Kimberly A. Dodd & Wei Jia. (2021) Validation of a binary ethylenimine (BEI) inactivation procedure for biosafety treatment of foot-and-mouth disease viruses (FMDV), vesicular stomatitis viruses (VSV), and swine vesicular disease virus (SVDV). Veterinary Microbiology 252, pages 108928.
Crossref
Crossref
Jeremy Baldwin & Nikolai Petrovsky. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
533
549
.
Kenneth Lundstrom. 2021. DNA Vaccines. DNA Vaccines
33
47
.
Giulietta Saletti, Thomas Gerlach, Janina M. Jansen, Antonia Molle, Husni Elbahesh, Martin Ludlow, Wentao Li, Berend-Jan Bosch, Albert D. M. E. Osterhaus & Guus F. Rimmelzwaan. (2020) Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports 10:1.
Crossref
Crossref
Caroline E. R. Rowell & Hana M. Dobrovolny. (2020) Energy Requirements for Loss of Viral Infectivity. Food and Environmental Virology 12:4, pages 281-294.
Crossref
Crossref
Kenneth Lundstrom. (2020) Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19. Viruses 12:11, pages 1324.
Crossref
Crossref
Thomas J.M. Michiels, Christian Schöneich, Martin R.J. Hamzink, Hugo D. Meiring, Gideon F.A. Kersten, Wim Jiskoot & Bernard Metz. (2020) Novel Formaldehyde-Induced Modifications of Lysine Residue Pairs in Peptides and Proteins: Identification and Relevance to Vaccine Development. Molecular Pharmaceutics 17:11, pages 4375-4385.
Crossref
Crossref
Young Hun Chung, Veronique Beiss, Steven N. Fiering & Nicole F. Steinmetz. (2020) COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 14:10, pages 12522-12537.
Crossref
Crossref
Shalin S. Patel, Jeremy Kalma & Eric M. Bluman. (2020) Understanding COVID-19 Vaccines and Their Development. Journal of Bone and Joint Surgery 102:20, pages 1759-1769.
Crossref
Crossref
Kenneth Lundstrom. (2020) The Current Status of COVID-19 Vaccines. Frontiers in Genome Editing 2.
Crossref
Crossref
Oday A. Aljumaili, Muhammad B. Bello, Swee K. Yeap, Abdul R. Omar & Aini Ideris. (2020) Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants. Onderstepoort Journal of Veterinary Research 87:1.
Crossref
Crossref
Wilson C. K. Poon, Aidan T. Brown, Susana O. L. Direito, Daniel J. M. Hodgson, Lucas Le Nagard, Alex Lips, Cait E. MacPhee, Davide Marenduzzo, John R. Royer, Andreia F. Silva, Job H. J. Thijssen & Simon Titmuss. (2020) Soft matter science and the COVID-19 pandemic. Soft Matter 16:36, pages 8310-8324.
Crossref
Crossref
Sonali Kochhar, Jean-Louis Excler, Denny Kim, James S. Robertson, Patricia E. Fast, Richard C. Condit, Stephen Drew, David Wood, Marc Gurwith, Bettina Klug, Mike Whelan, Najwa Khuri-Bulos, Tamala Mallett Moore, Emily R. Smith & Robert T. Chen. (2020) The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Vaccine 38:39, pages 6184-6189.
Crossref
Crossref
Archana Madhav, Tanshi Mehrotra, Pallavi Sinha & Ankur Mutreja. (2020) Vaccines for neglected, emerging and re-emerging diseases. Seminars in Immunology 50, pages 101423.
Crossref
Crossref
Jasmin Fertey, Martin Thoma, Jana Beckmann, Lea Bayer, Julia Finkensieper, Susann Reißhauer, Beatrice Sarah Berneck, Leila Issmail, Jessy Schönfelder, Javier Portillo Casado, Andre Poremba, Frank-Holm Rögner, Bastian Standfest, Gustavo R. Makert, Lia Walcher, Ann-Kathrin Kistenmacher, Stephan Fricke, Thomas Grunwald & Sebastian Ulbert. (2020) Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities. Scientific Reports 10:1.
Crossref
Crossref
Christin Scheller, Finja Krebs, Robert Minkner, Isabel Astner, Maria Gil‐Moles & Hermann Wätzig. (2020) Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control. ELECTROPHORESIS 41:13-14, pages 1137-1151.
Crossref
Crossref
Satya P. Gupta. (2020) A Perspective of Viruses and the Outbreak of a Novel Coronavirus SARS-CoV- 2. Current Enzyme Inhibition 16:2, pages 107-114.
Crossref
Crossref
Khaled A. Abdelrahma, Alaa A. Ghazy & Emad Beshir Ata. (2020) Better Understanding of Important Aspects Associated with Vaccines Development for Controlling Viral Diseases in Animals. International Journal of Dairy Science 15:3, pages 114-122.
Crossref
Crossref
Qianyu Lin, Jason Y. C. Lim, Kun Xue, Pek Yin Michelle Yew, Cally Owh, Pei Lin Chee & Xian Jun Loh. (2020) Sanitizing agents for virus inactivation and disinfection. VIEW 1:2.
Crossref
Crossref
Kenneth Lundstrom. (2020) Coronavirus Pandemic—Therapy and Vaccines. Biomedicines 8:5, pages 109.
Crossref
Crossref
Jasmin Fertey, Lea Bayer, Sophie Kähl, Rukiya M. Haji, Anke Burger-Kentischer, Martin Thoma, Bastian Standfest, Jessy Schönfelder, Javier Portillo Casado, Frank-Holm Rögner, Christoph Georg Baums, Thomas Grunwald & Sebastian Ulbert. (2020) Low-Energy Electron Irradiation Efficiently Inactivates the Gram-Negative Pathogen Rodentibacter pneumotropicus—A New Method for the Generation of Bacterial Vaccines with Increased Efficacy. Vaccines 8:1, pages 113.
Crossref
Crossref
Yohei Takeda, Yuko Okuyama, Hiroto Nakano, Yasunori Yaoita, Koich Machida, Haruko Ogawa & Kunitoshi Imai. (2019) Antiviral Activities of Hibiscus sabdariffa L. Tea Extract Against Human Influenza A Virus Rely Largely on Acidic pH but Partially on a Low-pH-Independent Mechanism. Food and Environmental Virology 12:1, pages 9-19.
Crossref
Crossref
Wern Hann Ng, Xiang Liu & Suresh Mahalingam. (2020) Development of vaccines for SARS-CoV-2. F1000Research 9, pages 991.
Crossref
Crossref
Xiumiao He, Weiwei Wang, Guo Chen, Pengtao Jiao, Zhonghua Ji, Lin Yang & Ping Wei. (2019) Serological study reveal different antigenic IBDV strains prevalent in southern China during the years 2000–2017 and also the antigenic differences between the field strains and the commonly used vaccine strains. Veterinary Microbiology 239, pages 108458.
Crossref
Crossref
Klausberger, Leneva, Falynskova, Vasiliev, Poddubikov, Lindner, Kartaschova, Svitich, Stukova, Grabherr & Egorov. (2019) The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections. Vaccines 7:4, pages 187.
Crossref
Crossref
Ailar Sabbaghi, Seyed Mohammad Miri, Mohsen Keshavarz, Mohsen Zargar & Amir Ghaemi. (2019) Inactivation methods for whole influenza vaccine production. Reviews in Medical Virology 29:6.
Crossref
Crossref
Gagandeep Singh, Pankaj Singh, Angela Pillatzki, Eric Nelson, Brett Webb, Steven Dillberger-Lawson & Sheela Ramamoorthy. (2019) A Minimally Replicative Vaccine Protects Vaccinated Piglets Against Challenge With the Porcine Epidemic Diarrhea Virus. Frontiers in Veterinary Science 6.
Crossref
Crossref
Giovana Basso, Juliana F. Cargnelutti, Amanda L. Oliveira, Thiago V. Acunha, Rudi Weiblen, Eduardo F. Flores & Bernardo A. Iglesias. (2019) Photodynamic inactivation of selected bovine viruses by isomeric cationic tetra-platinated porphyrins. Journal of Porphyrins and Phthalocyanines 23:09, pages 1041-1046.
Crossref
Crossref
Minna M. Hankaniemi, Virginia M. Stone, Amir-Babak Sioofy-Khojine, Suvi Heinimäki, Varpu Marjomäki, Heikki Hyöty, Vesna Blazevic, Olli H. Laitinen, Malin Flodström-Tullberg & Vesa P. Hytönen. (2019) A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine. Vaccine 37:40, pages 5962-5971.
Crossref
Crossref
María S. Lucero, Matías Richetta, Silvina Chimeno Zoth, Juan Jaton, Silvina Pinto, Zulma Canet, Analía Berinstein & Evangelina Gómez. (2019) Plant-based vaccine candidate against Infectious bursal disease: An alternative to inactivated vaccines for breeder hens. Vaccine 37:36, pages 5203-5210.
Crossref
Crossref
Anak Agung Ayu Mirah AdiI Nyoman Mantik AstawaI Gusti Agung Arta Putra. (2019) The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates. Veterinary World 12:6, pages 758-764.
Crossref
Crossref
Kenneth Lundstrom. (2019) Plasmid DNA-based Alphavirus Vaccines. Vaccines 7:1, pages 29.
Crossref
Crossref
Pran Kishore Deb, Omar Husham Ahmed Al-Attraqchi, Johnson Stanslas, Amal Al-Aboudi, Noor Al-Attraqchi & Rakesh K. Tekade. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
153
189
.
Hojeong Shin, Se‐Jin Park, Yeajee Yim, Jungho Kim, Chulwon Choi, Cheolhee Won & Dal‐Hee Min. (2018) Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles. Advanced Therapeutics 1:7.
Crossref
Crossref
Yulema Valero, Djamal Mokrani, Elena Chaves-Pozo, Marta Arizcun, Mustapha Oumouna, José Meseguer, M.Ángeles Esteban & Alberto Cuesta. (2018) Vaccination with UV-inactivated nodavirus partly protects European sea bass against infection, while inducing few changes in immunity. Developmental & Comparative Immunology 86, pages 171-179.
Crossref
Crossref
M.O. Bwana, L.W. Njagi, P.N. Nyaga, P.G. Mbuthia, L.C. Bebora, M.W. Wahome, W.U. Mutinda & P.M. Kitala. (2018) Stinging nettle and neem enhance antibody response to local killed and imported live infectious bursal disease vaccines in indigenous chicken in Kenya. Poultry Science 97:2, pages 447-454.
Crossref
Crossref
Xia Li, Xiupeng Wang & Atsuo Ito. (2018) Tailoring inorganic nanoadjuvants towards next-generation vaccines. Chemical Society Reviews 47:13, pages 4954-4980.
Crossref
Crossref
Evangelina Gómez, María Soledad Lucero, Matías Richetta, Silvina Chimeno Zoth & Analía Berinstein. 2018. Prospects of Plant-Based Vaccines in Veterinary Medicine. Prospects of Plant-Based Vaccines in Veterinary Medicine
169
187
.
Kenneth Lundstrom. (2016) Replicon RNA Viral Vectors as Vaccines. Vaccines 4:4, pages 39.
Crossref
Crossref
Robert M. Lawrence, James D. Zook & Brenda G. Hogue. (2016) Full inactivation of alphaviruses in single particle and crystallized forms. Journal of Virological Methods 236, pages 237-244.
Crossref
Crossref
Weiwei Zeng, Qing Wang, Yingying Wang, Changchen Zhao, Yingying Li, Chunbin Shi, Shuqin Wu, Xinjian Song, Qiwen Huang & Shoujun Li. (2016) Immunogenicity of a cell culture-derived inactivated vaccine against a common virulent isolate of grass carp reovirus. Fish & Shellfish Immunology 54, pages 473-480.
Crossref
Crossref
Theone C. Kon, Adrian Onu, Laurentiu Berbecila, Emilia Lupulescu, Alina Ghiorgisor, Gideon F. Kersten, Yi-Qing Cui, Jean-Pierre Amorij & Leo Van der Pol. (2016) Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes. PLOS ONE 11:3, pages e0150700.
Crossref
Crossref
Kenneth Lundstrom. 2016. Vaccine Design. Vaccine Design
313
328
.
Xiaojun Zuo, Xiaona Chu & Jiangyong Hu. (2015) Effects of water matrix on virus inactivation using common virucidal techniques for condensate urine disinfection. Chemosphere 136, pages 118-124.
Crossref
Crossref
Renata C. Pereira, Andrea N.M.R. Silva, Marta Cristina O. Souza, Marlon V. Silva, Patrícia P.C.C. Neves, Andrea A.M.V. Silva, Denise D.C.S. Matos, Miguel A.O. Herrera, Anna M.Y. Yamamura, Marcos S. Freire, Luciane P. Gaspar & Elena Caride. (2015) An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Vaccine 33:35, pages 4261-4268.
Crossref
Crossref
Sarah K. Fritschi, Amarallys Cintron, Lan Ye, Jasmin Mahler, Anika Bühler, Frank Baumann, Manuela Neumann, K. Peter R. Nilsson, Per Hammarström, Lary C. Walker & Mathias Jucker. (2014) Aβ seeds resist inactivation by formaldehyde. Acta Neuropathologica 128:4, pages 477-484.
Crossref
Crossref
K.A. Schat. 2014. Encyclopedia of Agriculture and Food Systems. Encyclopedia of Agriculture and Food Systems
315
332
.
Xiaonan Lu, Qian Liu, Javier A. Benavides-Montano, Anthony V. Nicola, D. Eric Aston, Barbara A. Rasco & Hector C. Aguilar. (2013) Detection of Receptor-Induced Glycoprotein Conformational Changes on Enveloped Virions by Using Confocal Micro-Raman Spectroscopy. Journal of Virology 87:6, pages 3130-3142.
Crossref
Crossref
Gary J. Nabel. (2013) Designing Tomorrow's Vaccines. New England Journal of Medicine 368:6, pages 551-560.
Crossref
Crossref